The clinical value of dynamic contrast-enhanced magnetic resonance imaging at 3.0T to detect prostate cancer - Abstract

OBJECTIVE: To compare dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and T2-weighted imaging (T2WI) at 3.0T for detection of prostate cancer.

METHODS: Patients with elevated prostate-specific antigen underwent T2WI and DCE-MRI prior to prostate needle biopsy. The sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of T2WI and DCE-MRI to diagnose prostate cancer were evaluated. The relationship between Gleason score and prostate cancer detection by DCE-MRI was evaluated.

RESULTS: Prostate adenocarcinoma was histopathologically confirmed in 44/75 patients. DCE-MRI had significantly higher sensitivity, accuracy and NPV than T2WI. The detection rate of prostate cancer by DCE-MRI was significantly better for tumours with Gleason score 7-9 than for those Gleason score 4-6.

CONCLUSION: DCE-MRI at 3.0T can significantly improve prostate cancer detection using simple visual diagnostic criteria, compared with T2WI.

Written by:
Zhang X, Quan X, Lu S, Huang F, Yang J, Chan Q, Lin T.   Are you the author?
Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Philips Healthcare, Hong Kong, China.  

Reference: J Int Med Res. 2014 Aug 4. pii: 0300060514541827.
doi: 10.1177/0300060514541827


PubMed Abstract
PMID: 25091389

UroToday.com Prostate Cancer Section

 

 

 

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe